Nueclear Web Banner
Users Online: 449
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
EDITORIAL
Year : 2012  |  Volume : 1  |  Issue : 1  |  Page : 1-4

A fresh look at oncology facts on south central Asia and SAARC countries


1 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
2 Department of Gynaecology Oncology, Jigme Dorji Wangchuk National Referral Hospital, Thimpu, Bhutan
3 Department of Radiation Oncology, Shaukhat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
4 Director, Bangladesh Cancer Hospital and Welfare Home, Dhaka, Bangladesh
5 Department of Clinical Oncology, Lakeside Adventist Hospital, Kandy, Sri Lanka
6 Department of Medical Oncology, B&B Hospital, Lalitpur, Nepal
7 Chairman and Director, National Cancer Hospital, Lalitpur, Nepal

Date of Web Publication24-May-2012

Correspondence Address:
Vanita Noronha
Department of Medical Oncology, Tata Memorial Hospital, Mumbai
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-330X.96489

Rights and Permissions

How to cite this article:
Noronha V, Tsomo U, Jamshed A, Hai M A, Wattegama S, Baral R P, Piya M, Prabhash K. A fresh look at oncology facts on south central Asia and SAARC countries. South Asian J Cancer 2012;1:1-4

How to cite this URL:
Noronha V, Tsomo U, Jamshed A, Hai M A, Wattegama S, Baral R P, Piya M, Prabhash K. A fresh look at oncology facts on south central Asia and SAARC countries. South Asian J Cancer [serial online] 2012 [cited 2017 Nov 25];1:1-4. Available from: http://journal.sajc.org/text.asp?2012/1/1/1/96489

WHO divides the world into several regions. [1] One of them is South Central Asia. This consists of 14 countries - Islamic republic of Iran, 5 that were born from the former USSR (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan), and remaining 8 that are together called the SAARC countries (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka). The population of South Central Asia and SAARC Countries forms 26.68 % and 24.59 % of the world population, respectively [Table 1]. [2],[3],[4] As far as cancer in these regions is concerned, incidence of new cases is 11.24% and 10.23 % of the world's cases. Yet, the burden of cancer deaths as compared to the incidence is 68.85 % and 68.44 %, respectively. This compares poorly to the 59.74% for the world. This well-known fact reaffirms that these regions of the world need to improve their cancer management strategies.
Table 1: Comparison of population, cancer incidence, cancer deaths, and cancer prevalence rates in different regions

Click here to view


Facts about cancer in South Central Asia are shown in [Table 2]. For the entire population, the 5 most common cancers are cancer of cervix and uterus, breast cancer, lung cancer, oral cancer and Cancer of esophagus. [2],[3] Interestingly, the 5-year prevalence of cancers is significantly higher in females.
Table 2: Cancer facts in south central Asia

Click here to view


The Southern countries of Asia (India, Pakistan, Nepal, Bangladesh, Bhutan, Sri Lanka, Afghanistan, Maldives, Burma, and Tibet) share more than just a common love of chai, cricket, and Bollywood. We also share a matching oncologic profile, albeit with some regional differences. With respect to figures for South Central Asia, the SAARC countries contribute a burden of 91.10 % of incidence, 90.93% 5-year prevalence and 90.56% of cancer deaths [Table 1], [Table 3]. Hence, importance of focusing on oncology in SAARC countries cannot be over-emphasized.
Table 3: Incidence and deaths of cancer in SAARC countries

Click here to view


As an overview, in males, lung and oral cancer rank as the top 2 prevalent cancers while in women, breast, and cervical cancer take the top 2 spots. [5] Let us now take the SAARC nations of India, Pakistan, Bangladesh, Bhutan, Nepal, and Sri Lanka that are coming together for this manuscript. For instance, the level of oncologic care varies widely across our countries as well as within each country. The number of trained oncologists varies from a high of 1500 in India to a low of 2 in Bhutan [Table 4].
Table 4: Insight into oncology status of SAARC Countries

Click here to view


We will also consider the 6 countries individually in terms of cancer burden and the level of oncologic expertise available.

Starting with India, there are 27 dedicated cancer hospitals and an additional 300 general or multispecialty hospitals that provide care to cancer patients. There are about 1 million patients diagnosed with cancer each year with the majority being diagnosed in an advanced stage, leading to a significant number of deaths. Cancer is the 4 th leading cause of death in India in the 25 to 69 year age group, ranking behind cardiovascular disease, respiratory disease, and tuberculosis. There are 1500 trained oncologists who take care of these patients, compared to a total number of over 4.4 lakh doctors of all specialties. India has an official national cancer control program, that mainly focuses on primary, secondary and tertiary cancer prevention strategies, a national cancer registry program, 5 oncology societies, 300 radiotherapy machines, produces 5 cancer journals and organizes at least 55 oncology-centric conferences annually. Although this may seem like a situation of plenty, in actuality, this is not the case. There are over 1 billion people in India, of which there are about 24 lakh persons with cancer at any given point of time according to the WHO report. Thus, the ratio of cancer patients to oncologists in India is 1600 to 1. Compare this to the results of a study commissioned by ASCO in 2008 that predicted that by the year 2020, there will be 12,500 oncologists in America available to care for the nearly 1.4 million Americans diagnosed with cancer each year, leading to a ratio of about 100 patients to 1 oncologist. [5],[6] The same ASCO report actually raised concerns over the growing shortage in the oncologist workforce, in spite of this seemingly enviable ratio! Their analysis projected an increase of 14% in oncology training seats, whereas the demand for patients requiring oncology visits was expected to increase by 48%. This was mainly due to the growth and aging of the population as well as the increase in the number of cancer survivors. Yet, only 30% expected that the government shall fund new positions to increase training capacity, and in fact as many as 24% did not know where such funding might be forthcoming. As a result, the training program directors at oncology centers in USA were of the opinion that there will not be a significant increase in the number of oncology training positions during the next 5 years. In the light of the current limitations (financial, administrative, and others) in India (and other SAARC countries), we can expect that our preparedness for the future, at best, is woefully inadequate.

The oncology situation in the other SAARC countries is roughly comparable to that in India in terms of cancer patients to doctors. However, due to the smaller population and smaller actual numbers of oncologists, all types and level of oncology specialists may not be available. For example, there are 2 qualified oncologists in Bhutan, both of whom are surgeons. Thus, there is no trained medical oncologist in Bhutan, and no radiotherapy machines in a country with a population of 7.25 lakhs. Bhutan had 639 cancer patients registered in the year 2010. If requiring oncologic surgeries, especially gynecologic oncological surgeries, patients are able to benefit from treatment within Bhutan. However, the majority, needing radiotherapy or chemotherapy currently, have to make their way to India for management. Recently, the Jigme Dorji Wangchuck National Referral Hospital (JDWNRH) established a chemotherapy unit, taking into account the increasing number of cancer patients noted in the country (albeit at the expense of abandoning plans for a new burns unit). Ongoing initiatives to prevent cancer include  Pap smear More Details program and HPV vaccination for the whole country, hepatitis B vaccination for all newborns and a nationwide ban on sale of tobacco - truly commendable activities.

Pakistan, with its population of over 173 million people, is the 6 th most populous country in the world. There are over 1.4 million cancer patients in Pakistan, and approximately 150,000 new cancer patients are added each year. There are 20 cancer hospitals and 50 other hospitals where cancer patients can be cared for. There are 125 trained oncologists, 25 radiotherapy machines, 6 oncology-centric conferences, and provision for specialized oncology training in Pakistan. Pakistan recently established the Karachi Cancer Registry and the Pakistan Cancer Control Program 2. [7] However, Pakistan has yet to publish an oncology journal.

Bangladesh, at 142 million people, is the 9 th most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about 2 lakh patients newly-diagnosed with cancer each year. In order to care for these patients, there are 150 qualified oncologists, 18 cancer hospitals and an additional 50 general hospitals that accept and provide care to cancer patients. Bangladesh publishes 3 oncology journals, organizes 20 oncology conferences annually, has 3 oncology societies, an oncology training program, and several hospital-based and population-based cancer registries. Therefore, oncology specialty is relatively well-established in Bangladesh, but there is no national cancer program yet.

Nepal, with its population of almost 30 million, has about 30,000 new cancer patients each year. These patients can receive oncologic care from 40 trained oncologists in 5 cancer centers. There is provision for radiotherapy, postgraduate oncology training programs, and a national cancer policy. Nepal also does not publish an oncology journal.

Sri Lanka, with a population of 20 million, also has a well-established oncologic program. There are approximately 15,000 new patients diagnosed with cancer in Sri Lanka annually. There are 6 cancer hospitals and 18 qualified oncologists. Radiation therapy is relatively easily available with 11 radiation therapy machines in the country, including a recently commissioned linear accelerator at the National Cancer Center, Maharagama, Colombo.

There is a 3 rd issue that remains an important factor in this region. So far, we have discussed global figures (Globocan, IARC, WHO, etc) and opinions of experts in the SAARC countries [Table 4]. What about data from local registries that show that Globocan data is underestimating cancer incidence in our countries? Let us take the example of breast cancer in India. The Indian Council of Medical Research population-based cancer registry of New Delhi shows the incidence to be 29.3 per 100,000 of the population in 1994-95. [8],[9] And, the Indian Cancer Society's Maharashtra population-based registry shows it to be 26.8 per 100,000 of the population in 2001. [9],[10] Both these figures are higher than the < 19.5 incidence per 100,000 population showed in Globocan 2002 data. [11]

Thus, the infrastructure and human resources for oncologic care in South Asia is steadily improving. However, we have a long way to go. By providing a forum to share clinical observations, educational material, research findings, and news of conferences and meetings, we hope that the SAJC will provide an impetus to accelerate advances in cancer care for South Asia and ultimately help us provide the best care possible to the quarter of the world's population that has made this region their home.

 
  References Top

1.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. Ca Cancer J Clin 2011;61:69-90.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Cancer Worldwide, Sept 2011. Available from: http://publications.cancerresearchuk.org/publicationformat/formatstats/statsworldwide20051.html. [Last cited in 2012].  Back to cited text no. 2
    
3.GLOBOCAN 2008 v. 1.2. Cancer Incidence and Mortality Worldwide IARC 2010. Available from: http:/globocan.iarc.fr. [Last cited in 2011 Feb].   Back to cited text no. 3
    
4.PRBs world population datasheet 2011. The world at 7 Billion: A PRB Interactive Map. Available from: http://www.prb.org. [Last cited in 2012].   Back to cited text no. 4
    
5.Moore MA, Ariyaratne Y, Badar F, Bhurgri Y, Datta K, Mathew A, et al. Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev 2010;11 Suppl 2:49-66.   Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Erikson C, Schulman S, Kosty M, Hanley A. Oncology Workforce: Results of the ASCO 2007 Program Directors Survey. J Oncol Pract 2009;5:62-4.   Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Bhurgri Y. Karachi Cancer Registry Data--implications for the National Cancer Control Program of Pakistan. Asian Pac J Cancer Prev 2004;5:77-82.  Back to cited text no. 7
[PUBMED]  [FULLTEXT]  
8.Raina V, Tyagi B, Manoharan N. Population based cancer registry Delhi. Available from: http://www.icmr.nic.in/ncrp/report_pop_2001-04/05_Delhi%20Pages%20154-173.pdf. [Last cited in 2012].   Back to cited text no. 8
    
9.Nandakumar A, Ramnath T, Roselind F, Shobaba B, Prabhu K. Two year report of the population based cancer registries 1999-2000. Available from: http://www.icmr.nic.in/ncrp/1999-00/PBCR%20Report%201999_00.pdf. [Last cited in 2012].  Back to cited text no. 9
    
10.Kurkure AP, Yoele B, Koyande S. Cancer incidence and mortality in greater Mumbai 2006. Available from: http://www.indiancancersociety.org/cancer-resgistry/cancer-registry.htm. [Last cited in 2012].  Back to cited text no. 10
    
11.Parkin M, Bray, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74-108.  Back to cited text no. 11
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]


This article has been cited by
1 Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline
Vijay Patil,Vanita Noronha,Amit Joshi,Purvish Parikh,Atanu Bhattacharjee,Santam Chakraborty,Sunny Jandyal,Vamshi Muddu,Anant Ramaswamy,K. Govinda Babu,Nilesh Lokeshwar,Sachin Hingmire,Nikhil Ghadyalpatil,Shripad Banavali,Kumar Prabhash
Journal of Global Oncology. 2017; 3(4): 346
[Pubmed] | [DOI]
2 National Cancer Control Programme in India: Proposal for Organization of Chemotherapy and Systemic Therapy Services
Seema Gulia,Manju Sengar,Rajendra Badwe,Sudeep Gupta
Journal of Global Oncology. 2016; : JGO001818
[Pubmed] | [DOI]
3 Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases
Md. Nur Kabidul Azam,Md. Mizanur Rahman,Samanta Biswas,Md. Nasir Ahmed
International Scholarly Research Notices. 2016; 2016: 1
[Pubmed] | [DOI]
4 Palliative care in South Asia: a systematic review of the evidence for care models, interventions, and outcomes
Taranjit Singh,Richard Harding
BMC Research Notes. 2015; 8(1)
[Pubmed] | [DOI]
5 Challenges to effective cancer control in China, India, and Russia
Paul E Goss,Kathrin Strasser-Weippl,Brittany L Lee-Bychkovsky,Lei Fan,Junjie Li,Yanin Chavarri-Guerra,Pedro E R Liedke,C S Pramesh,Tanja Badovinac-Crnjevic,Yuri Sheikine,Zhu Chen,You-lin Qiao,Zhiming Shao,Yi-Long Wu,Daiming Fan,Louis W C Chow,Jun Wang,Qiong Zhang,Shiying Yu,Gordon Shen,Jie He,Arnie Purushotham,Richard Sullivan,Rajendra Badwe,Shripad D Banavali,Reena Nair,Lalit Kumar,Purvish Parikh,Somasundarum Subramanian,Pankaj Chaturvedi,Subramania Iyer,Surendra Srinivas Shastri,Raghunadhrao Digumarti,Enrique Soto-Perez-de-Celis,Dauren Adilbay,Vladimir Semiglazov,Sergey Orlov,Dilyara Kaidarova,Ilya Tsimafeyeu,Sergei Tatishchev,Kirill D Danishevskiy,Marc Hurlbert,Caroline Vail,Jessica St Louis,Arlene Chan
The Lancet Oncology. 2014; 15(5): 489
[Pubmed] | [DOI]
6 Patterns of cancer cell sphere formation in primary cultures of human oral tongue squamous cell carcinoma and neck nodes
Saima Faisal,Raza Hussain,Muhammad Tahseen,Asif Loya,Chris Sutton
Cancer Cell International. 2014; 14(1)
[Pubmed] | [DOI]
7 Cancer Control in Bangladesh
S. A. Hussain,R. Sullivan
Japanese Journal of Clinical Oncology. 2013;
[Pubmed] | [DOI]
8 Cancer Care in Pakistan
A. Yusuf
Japanese Journal of Clinical Oncology. 2013; 43(8): 771
[Pubmed] | [DOI]
9 Cancer care scenario in Bangladesh
Uddin, AK and Khan, ZJ and Islam, J and Mahmud, AM and others
South Asian Journal of Cancer. 2013; 2(2): 102
[VIEW] | [PDF] | [DOI]
10 Cancer control in South Asia: Awareness is key to success
Hussain, SM and others
South Asian Journal of Cancer. 2013; 2(2): 55
[VIEW] | [PDF] | [DOI]
11 Improving cancer care in Pakistan
Jamshed, A and Syed, AA and Shah, MA and Jamshed, S and others
South Asian Journal of Cancer. 2013; 2(1): 36
[VIEW] | [PDF] | [DOI]
12 Challenges in launching multinational oncology clinical trials in India
Saini, KS and Agarwal, G and Jagannathan, R and Metzger-Filho, O and Saini, ML and Mistry, K and Ali, R and Gupta, S and others
South Asian Journal of Cancer. 2013; 2(1): 44
[VIEW] | [PDF] | [DOI]
13 Optimizing patient outcome: Of equal importance in the palliative setting
Parikh, P and Narayanan, P and Bhattacharyya, GS and others
Indian J Cancer. 2012; 49(3): 255
[VIEW] | [DOI]
14 Indian Guidelines and Protocols in Oncology: Solid Tumors and Hematological Malignancies
Parikh, Purvish M
. ;
[VIEW] | [PDF]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References
Article Tables

 Article Access Statistics
    Viewed3530    
    Printed124    
    Emailed1    
    PDF Downloaded561    
    Comments [Add]    
    Cited by others 14    

Recommend this journal